Agilent NovoCyte Advanteon Flow Cytometer

The Agilent NovoCyte Advanteon Flow Cytometer is being procured by the National Institutes of Health through the Office of the Director, Office of Laboratory Animal Welfare, under solicitation number 75N98026Q00590, with a response deadline of June 22, 2026. This benchtop flow cytometry system is intended to enhance the capabilities of the Section on Regulatory Ribonucleic Acids, which investigates how ribonucleic acid binding proteins and microRNAs govern gene expression, particularly in disease contexts such as cancer, hearing loss, and diabetes. The instrument will significantly boost experimental throughput and streamline data acquisition and analysis, allowing for more efficient and high-parameter cellular studies critical to uncovering molecular mechanisms underlying these conditions and guiding future therapeutic development. The equipment will be delivered and operated at the agency’s facility in Bethesda, Maryland, with James B. Law serving as the primary point of contact for inquiries and submissions.